A Study of TQB2450 Combined With Anlotinib in Subjects With Ovarian Cancer

Condition:   Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Interventions:   Drug: TQB2450;   Drug: Anlotinib Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials